DC
ANRO icon

Diametric Capital’s Alto Neuroscience ANRO Stock Holding History

Diametric Capital’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Buy
+10,315
New +$191K 0.06% 372
2024
Q2 		– Sell
-16,200
Closed -$249K – 482
2024
Q1 		$249K Buy
+16,200
New +$254K 0.14% 205

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Diametric Capital's ANRO Position: Q1 2026 in Review

Diametric Capital opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 10,315 shares worth $232K. The stake represents 0.06% of the portfolio and ranks #372 among its holdings. This is a return to the name: Diametric Capital previously reported a position in ANRO as recently as Q1 2024.

Diametric Capital first reported a position in ANRO in Q1 2024 and has held it in 2 quarters since. The position peaked at $249K in Q1 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Diametric Capital held 10,315 shares of Alto Neuroscience worth $232K as of Q1 2026.
  • Alto Neuroscience was a new Diametric Capital position in Q1 2026.
  • Alto Neuroscience made up 0.06% of Diametric Capital's portfolio in Q1 2026, its #372 holding.
  • Diametric Capital first reported a position in Alto Neuroscience in Q1 2024 and has held it in 2 quarters since.
  • Diametric Capital's Alto Neuroscience position peaked at $249K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.